Anastrozole is a medication primarily used in the treatment of hormone-receptor-positive breast cancer in postmenopausal women. It falls under the category of aromatase inhibitors, which work by blocking the conversion of androgens to estrogens in the body, thereby reducing estrogen levels and limiting the growth of certain types of breast cancers that thrive on this hormone.
To avoid mistakes with dosage and schedule, read everything about Anastrozole on https://irishpowerpharmacy.com/categories/aromatase-inhibitors/anastrozole/ before ordering.
How Anastrozole Works
Anastrozole inhibits the aromatase enzyme, effectively lowering estrogen levels. This reduction helps in slowing or stopping the growth of hormone-sensitive tumors in breast tissue. The mechanism can be summarized as follows:
- Suppression of Estrogen Production: Anastrozole significantly decreases the estrogen levels produced by the body.
- Targeting Estrogen-Receptor Positive Cancer: It specifically targets cancers that rely on estrogen to grow.
- Improvement in Survival Rates: Clinical trials have shown that Anastrozole can improve survival rates in women with early-stage breast cancer.
Dosage and Administration
The typical dosage for Anastrozole is one 1 mg tablet taken once daily. It is important to follow the prescribed dosage and schedule closely to ensure the medication’s effectiveness and minimize potential side effects.
Side Effects of Anastrozole
While Anastrozole is generally well-tolerated, some patients may experience side effects. Common side effects include:
- Hot flashes
- Joint pain or stiffness
- Fatigue
- Nausea
- Osteoporosis or bone fractures
Patients should report any severe or unusual side effects to their healthcare provider promptly.
Who Should Not Use Anastrozole?
Anastrozole is not suitable for everyone. It is typically contraindicated in:
- Women who are pregnant or breastfeeding
- Patients with a known hypersensitivity to Anastrozole or any of its components
- Women with premenopausal breast cancer or those with estrogen receptor-negative tumors
Conclusion
Anastrozole has become an essential part of breast cancer treatment for many postmenopausal women with hormone-receptor-positive tumors. Understanding the medication’s use, potential side effects, and the importance of adherence to prescribed dosages can significantly impact treatment outcomes. Always consult your healthcare provider for personalized advice and thorough information about your cancer treatment regimen.